Physician
Cumberland County Hospital Association INC
Cumberland County Hospital Association INC was paid $8.60M by Medicaid between Jan 2018 and Dec 2024, across 112 billing codes. Its largest line is 74176, Computed tomography, abdomen and pelvis; without contrast material — 12% of everything it billed.
33Billing provider infoCUMBERLAND COUNTY HOSPITAL ASSOCIATION INC
BURKESVILLE, KY 42717
BURKESVILLE, KY 42717
33aNPI1073567608assigned 05/19/2006
33bProvider typeEmergency Medicine Physician
28Total paid$8.60M
24GClaims270,286
24DCodes billed112
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Emergency Medicine Physician providers in Kentucky
Rank by total paid#5 of 91
Median peer was paid$34K
This provider vs. median252×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 44,782 | $1.07M | |
| 2019 | 42,813 | $1.16M | |
| 2020 | 39,009 | $979K | |
| 2021 | 40,984 | $1.42M | |
| 2022 | 41,212 | $1.59M | |
| 2023 | 35,539 | $1.35M | |
| 2024incomplete | 25,947 | $1.03M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | 12% | 2,558 | 2,021 | $1.04M |
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 11% | 15,919 | 13,002 | $928K |
| 80053 | Comprehensive metabolic panel | 8.1% | 21,129 | 15,707 | $693K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 6.4% | 14,453 | 12,366 | $551K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 5.1% | 43,251 | 21,340 | $442K |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | 4.8% | 6,640 | 5,695 | $411K |
| 70450 | Computed tomography, head or brain; without contrast material | 4.2% | 1,405 | 1,074 | $360K |
| 71046 | Radiologic examination, chest; 2 views | 3.3% | 4,066 | 3,262 | $284K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 3.2% | 5,328 | 3,525 | $272K |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | 3.1% | 5,036 | 1,069 | $271K |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | 2.8% | 6,412 | 5,751 | $244K |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 2.8% | 2,560 | 1,828 | $238K |
100 more codes
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | 2.7% | 5,023 | $232K |
| 87634 | 2.6% | 4,033 | $227K | |
| 80061 | Lipid panel | 2.6% | 5,583 | $222K |
| 71045 | Radiologic examination, chest; single view | 2.3% | 3,281 | $194K |
| 84443 | Thyroid stimulating hormone (TSH) | 2.2% | 6,576 | $187K |
| G0378 | Hospital observation service, per hour | 2.1% | 1,538 | $182K |
| 36415 | Collection of venous blood by venipuncture | 1.6% | 30,077 | $136K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 1.5% | 3,597 | $130K |
| 84439 | 1.3% | 8,764 | $110K | |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | <1% | 1,427 | $85K |
| 84484 | <1% | 2,210 | $72K | |
| 81001 | <1% | 8,332 | $67K | |
| 87260 | <1% | 389 | $62K | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 3,727 | $59K |
| 83874 | <1% | 2,081 | $49K | |
| C9803 | Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | <1% | 6,428 | $48K |
| 82553 | <1% | 2,108 | $46K | |
| 83605 | <1% | 6,118 | $45K | |
| 82150 | <1% | 2,104 | $41K | |
| 87088 | <1% | 4,245 | $41K | |
| 83690 | <1% | 2,155 | $41K | |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 747 | $36K |
| 82607 | <1% | 1,679 | $33K | |
| 71250 | <1% | 99 | $30K | |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 1,636 | $29K |
| 97161 | <1% | 359 | $28K | |
| 86677 | <1% | 533 | $23K | |
| 87186 | <1% | 1,770 | $20K | |
| 83880 | <1% | 455 | $18K | |
| 81025 | <1% | 715 | $18K | |
| G0103 | Prostate cancer screening; prostate specific antigen test (psa) | <1% | 1,431 | $18K |
| 73630 | <1% | 226 | $17K | |
| 87076 | <1% | 1,784 | $17K | |
| 99285 | Emergency room visit (most serious) | <1% | 131 | $17K |
| 85652 | <1% | 1,755 | $15K | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 769 | $14K |
| 73562 | <1% | 223 | $13K | |
| 85610 | <1% | 1,883 | $13K | |
| 84436 | <1% | 814 | $11K | |
| 73610 | <1% | 187 | $11K | |
| 87070 | <1% | 1,080 | $11K | |
| 86308 | <1% | 663 | $11K | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 973 | $10K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 327 | $9K |
| 87798 | Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism | <1% | 174 | $9K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 481 | $9K |
| 85730 | <1% | 869 | $8K | |
| 82728 | <1% | 768 | $8K | |
| 84479 | <1% | 560 | $7K | |
| 82043 | <1% | 1,741 | $7K | |
| 87040 | <1% | 271 | $7K | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 123 | $7K |
| 84145 | <1% | 115 | $6K | |
| 86769 | <1% | 443 | $6K | |
| 85379 | <1% | 167 | $6K | |
| 73030 | <1% | 102 | $5K | |
| 72100 | <1% | 110 | $5K | |
| 73130 | <1% | 64 | $5K | |
| 74022 | <1% | 49 | $5K | |
| 83615 | <1% | 437 | $5K | |
| 74019 | <1% | 86 | $5K | |
| 97140 | Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) | <1% | 55 | $5K |
| 82570 | <1% | 532 | $4K | |
| 87631 | <1% | 48 | $4K | |
| 83735 | <1% | 372 | $4K | |
| 99219 | <1% | 100 | $3K | |
| M0243 | Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring | <1% | 38 | $3K |
| 0012A | <1% | 320 | $3K | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 959 | $3K |
| 0011A | <1% | 340 | $3K | |
| 97032 | <1% | 78 | $2K | |
| 99239 | Hospital discharge day management, more than 30 minutes | <1% | 77 | $2K |
| 77080 | <1% | 39 | $1K | |
| 83540 | <1% | 102 | $1K | |
| 99217 | <1% | 64 | $1K | |
| 99232 | Hospital visit by a doctor, follow-up day | <1% | 101 | $880.66 |
| 73502 | <1% | 15 | $870.62 | |
| 94760 | <1% | 201 | $838.07 | |
| 0064A | <1% | 117 | $818.40 | |
| 99222 | Initial hospital care, per day, moderate complexity | <1% | 13 | $770.40 |
| 73110 | <1% | 16 | $758.27 | |
| 86757 | <1% | 20 | $754.22 | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 84 | $688.78 |
| 82948 | <1% | 117 | $608.15 | |
| 99231 | Subsequent hospital care, per day, straightforward or low complexity | <1% | 91 | $604.75 |
| 86603 | <1% | 13 | $583.54 | |
| 99221 | <1% | 38 | $500.58 | |
| 86738 | <1% | 13 | $487.37 | |
| J1642 | Injection, heparin sodium, (heparin lock flush), per 10 units | <1% | 282 | $469.58 |
| 86618 | <1% | 16 | $443.82 | |
| 87420 | <1% | 45 | $361.97 | |
| 82550 | <1% | 111 | $355.57 | |
| 93010 | Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | <1% | 165 | $181.99 |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 17 | $128.80 |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | <1% | 16 | $116.55 |
| J7030 | Infusion, normal saline solution , 1000 cc | <1% | 207 | $108.02 |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 26 | $94.88 |
| J2001 | Injection, lidocaine hcl for intravenous infusion, 10 mg | <1% | 42 | $47.16 |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 12 | $29.28 |
| J3490 | Unclassified drugs | <1% | 32 | $6.54 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialNEIKIRK, RICHARD (CEO)
| Provider | Location | Paid |
|---|---|---|
| Cumberland County Hospital Association INC | Burkesville, KY | $184K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.